StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

Investment analysts at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the medical technology company’s stock.

A number of other equities research analysts also recently weighed in on the company. Benchmark restated a “speculative buy” rating and set a $0.40 price target on shares of BIOLASE in a research report on Wednesday, October 2nd. Ascendiant Capital Markets decreased their price objective on BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd.

BIOLASE Price Performance

Shares of NASDAQ:BIOL opened at $0.01 on Friday. The company’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.06. The firm has a market capitalization of $300,663.00, a price-to-earnings ratio of 0.00 and a beta of 0.67. BIOLASE has a one year low of $0.02 and a one year high of $1.94.

Institutional Trading of BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC grew its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the period. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.